Regentys
Miami Lakes
About Regentys
Regentys, (“Asana” or the “Company”) is an early-stage Florida corporation focused on the development and commercialization of innovative medical devices for gastrointestinal applications. Asana’s lead product, ExtraCellular Matrix Hydrogel (ECMH), is a hydrogel composed of extracellular matrix derived from porcine tissue. ECMH creates an environment favorable for the body to grow new tissue in place of diseased or damaged tissue. Extracellular matrix has been proven to be safe and effective in esophageal repair, hernia grafts, vaginal slings, and burn and wound dressings. Asana’s novel application of this technology will treat ulcerative colitis (UC), a debilitating disease that renders the colon dysfunctional.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $1.6M
- Funding stage: M&A
- Last round: Convertible Note (May 2016)
- Website: regentys.com
- Phone: (844) 432-7262
Industries & Categories
Health Care, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/regentys-110980 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.